Dr Suchitra Sundaram reflects on time limited venetoclax combinations, next generation non covalent BTK inhibitors, and novel ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

Sequential BCL2 inhibitor therapy shows initial responses but lacks durability, especially in patients exposed to both BTKi ...

Lymphocytic choriomeningitis is a viral disease that sometimes affects the nervous system. The lymphocytic choriomeningitis virus typically infects rodents first, most frequently the common house rat.

What Is Chronic Lymphocytic Leukemia? Chronic lymphocytic leukemia (CLL) is a cancer that affects a type of white blood cell called lymphocytes. Lymphocytes help your body fight infection. They're ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved pirtobrutinib for certain adults with relapsed or refractory chronic lymphocytic leukemia ...

Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia A training/validation strategy was ...

Results from the BRUIN CLL-314 study comparing Jaypirca (pirtobrutinib) to Imbruvica (ibrutinib) – the first-ever head-to-head Phase 3 study versus a covalent BTK inhibitor to include treatment-naïve ...

This page lists all known medications that could potentially lead to 'Lymphocytic colitis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...